Historically, Biocurex moves upward on press releases, the increase depends on the significance of the press release, but until we see a revenue stream I afraid short term, this stock will continue to trade as it has in the past. Looks like we're cureently flying in a holding pattern. As you remember from Dr. Moro's question and answer sessions, a revenue stream is currently his top priority. No doubt when that happens, this stock should take off. We badly need a revenue stream.

Everyone here needs to keep in mind the potential that Biocurex has. I just finished reading an article about investing in penny stocks. The author states that penny stocks skyrocket for all sorts of reasons - the most important of which is future revenue. In the article he sites several examples, I shared two of the examples:

1.) Cell Therapeutics (CTIC) If you purchased the stock back in early 2009, you could have witnessed an increase of 4,100% when the stock climbed to over $2.00/share.

2.) Heartware International (HTWR) If you purchased this company in 2008 for .25/share, you could have watched this stock soar to $30/share in three months. One month after they received approval in the EU, Heartware was bought out by one of the industry giants.

By the way, I'm not promoting either company mentioned above, just trying to give some perspective as to the potential for Biocurex. Once Dr. Moro delivers on his promises, the share price of Biocurex of course will outperform all the major indices. Our patience will be rewarded.

JHMO